Nearly 90,000 Children’s Ibuprofen Bottles Recalled Nationwide

On March 16, the FDA classified the recall as Class II, warning the product could cause temporary or reversible health effects and advising consumers to stop using it immediately.

A total of 89,592 bottles are affected, specifically lot numbers 7261973A and 7261974A, both with an expiration date of January 31, 2027.

The recalled product is Children’s Ibuprofen Oral Suspension, a berry-flavored liquid for ages 2 to 11, sold in 4-ounce bottles nationwide under Taro Pharmaceuticals.

Strides Pharma began a recall on March 2 after receiving complaints that children’s liquid ibuprofen bottles contained a gel-like mass and black particles.

Incident reported at 200 Crossing Blvd.

On March 16, the FDA classified the recall as Class II, warning the product could cause temporary or reversible health effects and advising consumers to stop using it immediately.

A total of 89,592 bottles are affected, specifically lot numbers 7261973A and 7261974A, both with an expiration date of January 31, 2027.

The recalled product is Children’s Ibuprofen Oral Suspension, a berry-flavored liquid for ages 2 to 11, sold in 4-ounce bottles nationwide under Taro Pharmaceuticals.

Strides Pharma began a recall on March 2 after receiving complaints that children’s liquid ibuprofen bottles contained a gel-like mass and black particles.

Incident reported at 200 Crossing Blvd.

On March 16, the FDA classified the recall as Class II, warning the product could cause temporary or reversible health effects and advising consumers to stop using it immediately.

A total of 89,592 bottles are affected, specifically lot numbers 7261973A and 7261974A, both with an expiration date of January 31, 2027.

The recalled product is Children’s Ibuprofen Oral Suspension, a berry-flavored liquid for ages 2 to 11, sold in 4-ounce bottles nationwide under Taro Pharmaceuticals.

Strides Pharma began a recall on March 2 after receiving complaints that children’s liquid ibuprofen bottles contained a gel-like mass and black particles.

Incident reported at 200 Crossing Blvd.

On March 16, the FDA classified the recall as Class II, warning the product could cause temporary or reversible health effects and advising consumers to stop using it immediately.

A total of 89,592 bottles are affected, specifically lot numbers 7261973A and 7261974A, both with an expiration date of January 31, 2027.

The recalled product is Children’s Ibuprofen Oral Suspension, a berry-flavored liquid for ages 2 to 11, sold in 4-ounce bottles nationwide under Taro Pharmaceuticals.

Strides Pharma began a recall on March 2 after receiving complaints that children’s liquid ibuprofen bottles contained a gel-like mass and black particles.

Incident reported at 200 Crossing Blvd.

On March 16, the FDA classified the recall as Class II, warning the product could cause temporary or reversible health effects and advising consumers to stop using it immediately.

A total of 89,592 bottles are affected, specifically lot numbers 7261973A and 7261974A, both with an expiration date of January 31, 2027.

The recalled product is Children’s Ibuprofen Oral Suspension, a berry-flavored liquid for ages 2 to 11, sold in 4-ounce bottles nationwide under Taro Pharmaceuticals.

Strides Pharma began a recall on March 2 after receiving complaints that children’s liquid ibuprofen bottles contained a gel-like mass and black particles.

Incident reported at 200 Crossing Blvd.